BRK-B vs KMPR
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
KMPR presents as a classic value trap; while the Graham Number ($48.53) and P/B ratio (0.74) suggest deep value, the fundamental health is deteriorating. The Piotroski F-Score of 4/9 indicates only stable health, which is overshadowed by a catastrophic earnings trend featuring 0 beats in the last 4 quarters and a -57.11% average surprise. With YoY EPS growth collapsing by 83.4% and a bearish technical trend (0/100), the low valuation is a reflection of declining business quality rather than a market mispricing.
Compare Another Pair
Related Comparisons
BRK-B vs KMPR: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Kemper Corporation (KMPR) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.